Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
05/25/2011 | CN102070511A Method for preparing refined anthracene with content of more than 96 percent and carbazole with content of more than 98 percent |
05/25/2011 | CN102070510A 3-hydroxyindole derivatives and synthesis method and use thereof |
05/25/2011 | CN102070509A Method for preparing 3-allyl-3-hydroxy oxindole |
05/25/2011 | CN102070508A Indole compound and preparation method and application thereof |
05/25/2011 | CN102070507A Tri-indole compound and preparation method and application thereof |
05/25/2011 | CN102070506A Method for preparing 2-methylindoline |
05/25/2011 | CN102070459A Method for preparing amino-compound through catalytic reduction of nitro-compound |
05/25/2011 | CN102070451A Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof |
05/25/2011 | CN102070383A Method for preparing 1,2-diketone by performing catalytic oxidation on olefin |
05/25/2011 | CN101374808B Indole sulfonamide modulators of progesterone receptors |
05/25/2011 | CN101337875B Beta-dione compounds with terminal vinyl group |
05/25/2011 | CN101035867B Cyanine compound and optical recording materials |
05/24/2011 | US7947844 One-pot synthesis of benzisoindolenines used in the preparation of naphthalocyanines |
05/24/2011 | US7947728 Indole and indazole analogs as glycogen synthase activators |
05/24/2011 | US7947707 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
05/24/2011 | US7947704 2,4,6-phenyl-substituted cyclic ketoenols |
05/24/2011 | CA2453901C Substituted 4-aminocyclohexanols |
05/24/2011 | CA2450467C Methods for modulating bladder function |
05/24/2011 | CA2441235C Aryl and biaryl compounds having mch modulatory activity |
05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
05/24/2011 | CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors |
05/19/2011 | WO2011060302A1 Reduction of aldehydes and ketones to alcohols |
05/19/2011 | WO2011060113A1 Sulfenamide compounds for phototherapy |
05/19/2011 | WO2011059850A1 Hepatitis c virus inhibitors |
05/19/2011 | WO2011059463A1 Deuterated compounds for electronic applications |
05/19/2011 | WO2011059099A1 Aromatic amine derivative, and organic electroluminescent element comprising same |
05/19/2011 | WO2011057959A1 Indole and indazole derivatives as glycogen synthase activators |
05/19/2011 | US20110118478 Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses |
05/19/2011 | US20110118476 Process for Preparing Chiral Compounds |
05/19/2011 | US20110118469 Continuous flow synthesis of amino alcohols using microreactors |
05/19/2011 | US20110118455 Protecting group for indole group, nucleic acid-synthesizing amidite and nucleic acid-synthesizing method |
05/19/2011 | US20110118451 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
05/19/2011 | US20110118438 Cyanine-type compounds having an alkynyl linker arm |
05/19/2011 | US20110118318 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
05/19/2011 | US20110118303 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these |
05/19/2011 | US20110118210 Aminopropanol derivatives |
05/19/2011 | US20110117666 Fluorescent probe |
05/19/2011 | US20110117301 Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions |
05/19/2011 | US20110117057 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
05/19/2011 | US20110117015 Diagnostic Agents Selective Against Metalloproteases |
05/19/2011 | US20110115368 Arylamine compound and organic electroluminescent device |
05/19/2011 | US20110114934 New anthracene derivative and an organic electronic device using the same |
05/19/2011 | CA2780790A1 Hepatitis c virus inhibitors |
05/19/2011 | CA2780768A1 Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions |
05/18/2011 | EP2322643A1 Aldolases, nucleic acids encoding them and methods for making and using them |
05/18/2011 | EP2322508A1 Process for the manufacture of agomelatine and its intermediate |
05/18/2011 | EP2322507A1 Matrix metalloproteinase inhibitors |
05/18/2011 | EP2322501A1 4-dedimethylamino tetracycline compounds |
05/18/2011 | EP2321011A1 Diaryl compounds and uses thereof |
05/18/2011 | EP2320906A1 Heterocyclic amide derivatives as ep4 receptor antagonists |
05/18/2011 | EP1698618B1 Benzamide derivative |
05/18/2011 | CN1874996B Aminopropanol derivatives |
05/18/2011 | CN1805932B Process and intermediates for the preparation of hepatitis C virus protease inhibitor |
05/18/2011 | CN1720225B N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
05/18/2011 | CN102066323A Novel estrogen receptor ligands |
05/18/2011 | CN102066322A Compound having NPY Y5 receptor antagonist activity |
05/18/2011 | CN102060748A Multi-arm structure photoelectric-function material based on triindene elements |
05/18/2011 | CN102060747A Phenyl spirane ketone enol ester compound and application thereof |
05/18/2011 | CN102060746A Synthesis method and intermediate of 3-(substituted dihydroisoindolinone-2-group)-2, 6-piperadinedione |
05/18/2011 | CN102060745A Preparation method of (S)-indoline-2-carboxylic acid |
05/18/2011 | CN102060643A Preparation method of N-aryl amino acid |
05/18/2011 | CN101469000B Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer |
05/18/2011 | CN101316819B Methods for synthesis of 3-amino-1-arylpropyl indoles |
05/18/2011 | CN101090886B Process for the preparation of enantiomerically enriched indoline-2-carboxylic acid |
05/17/2011 | US7943785 Process for producing (Z)-1-phenyl-1-(N,N-diethylaminocarbonyl)-2- phthalimidomethylcyclopropane |
05/17/2011 | US7943783 Having an acylsulfonamide amine-reactive groups; crosslinker for amine containing material such as gel and hydrgels |
05/17/2011 | US7943778 Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives |
05/17/2011 | US7943658 Indole indane amide compounds useful as CB2 agonists and method |
05/17/2011 | US7943657 bleach or a disinfectant composition comprising an imido-alkanpercarboxylic acid |
05/17/2011 | US7943656 Crystal forms of saxagliptin and processes for preparing same |
05/17/2011 | US7943655 Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use |
05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
05/17/2011 | US7943605 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
05/17/2011 | US7943603 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
05/17/2011 | CA2514267C Malonamide derivatives as gamma-secretase inhibitors |
05/12/2011 | WO2011056985A2 Substituted heterocyclic compounds |
05/12/2011 | WO2011056929A1 Continuous flow synthesis of amino alcohols using microreactors |
05/12/2011 | WO2011056895A1 Ionic liquids comprising heteraromatic anions |
05/12/2011 | WO2011056440A1 Heterocyclic compounds as ccr1 receptor antagonists |
05/12/2011 | WO2011055932A2 Organic compound, organic electronic device using same, and terminal for same |
05/12/2011 | WO2011054837A2 Bifunctional prodrugs and drugs |
05/12/2011 | WO2011054525A1 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds |
05/12/2011 | WO2011054312A1 Method for preparing gliclazide and its intermediate |
05/12/2011 | WO2011034509A3 New benzathine salts of ace inhibitors, process for their preparation and their use for the treatment of cardiovascular diseases |
05/12/2011 | WO2010151541A8 Polymorphic form d of bazedoxifene acetate and methods of preparing same |
05/12/2011 | WO2010131054A9 Redox drug derivatives |
05/12/2011 | US20110112308 Salts of N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide |
05/12/2011 | US20110112307 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
05/12/2011 | US20110112306 Novel Sulfonic Acid Salt and Derivative thereof, Photo-Acid Generator, and Process for Production of Sulfonic Acid Salt |
05/12/2011 | US20110112296 Organometallic complexes as phosphorescent emitters in organic leds |
05/12/2011 | US20110112282 Ido inhibitors and therapeutic uses thereof |
05/12/2011 | US20110112161 Indole and indazole analogs as glycogen synthase activators |
05/12/2011 | US20110112148 Indoline compounds |
05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
05/12/2011 | US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
05/12/2011 | US20110112051 Dipeptidyl Peptidase-IV Inhibitors |
05/12/2011 | US20110112037 Crystal structure |
05/12/2011 | US20110111515 Reagent for measurement of reactive oxygen |
05/12/2011 | CA2780136A1 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds |
05/11/2011 | EP2318365A2 Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof |